Accordia Board of Directors

Our Board of Directors brings a wealth of experience and knowledge, providing strategic guidance and strong governance.

Henry A. McKinnell Jr, PhD, Chairman of the Board

Hank McKinnell retired as Chairman and CEO of Pfizer Inc, the world’s largest research-based pharmaceutical company, in 2006. Hank joined Pfizer in 1971 in Tokyo. Over the years, he held positions of increasing responsibility around the world, including service as president of Pfizer Asia, based in Hong Kong. He also served as Pfizer’s country manager-Iran/Afghanistan. In 1984 Hank relocated to New York, where he served as vice president-strategic planning, chief financial officer, president-Pfizer medical device group, president-Pfizer pharmaceuticals group, president and chief operating officer, president and chief executive officer from January 2001 to May 2001, and as chairman and chief executive officer, from May 2001 to August 2006, and chairman to December, 2006. Hank McKinnell is a member of the Boards of Directors of Moody’s Corporation, and ExxonMobil Corporation. Hank is a member of the Academic Alliance and chairman of Accordia Global Health Foundation, which build’s Africa’s capacity to fight infectious diseases through training, research, care and prevention. He is also chairman of the Connecticut Science Center. Hank is Chairman Emeritus of the Business Roundtable, an association of 170 CEO’s of America’s largest companies, the Pharmaceutical Research Manufacturers Association, the Food and Drug Law Institute, and the Medical Device Manufacturers Association. Hank also served as vice chairman of the World Economic Forum and as a member of the WEF Foundation Board of Trustees. Hank served on the President’s Advisory Council on HIV/AIDS. He is a director of the Medal of Honor Foundation, the Royal Shakespeare Company of America, the Japan Society, and a member of the Stanford University Graduate School of Business Advisory Council. He is a member of the Boards of Trustees of the New York City Public Library. Hank holds a Bachelor's Degree in business from the University of British Columbia, and M.B.A. and Ph.D. degrees from the Stanford University Graduate School of Business. Recent honors include the Grand Cordon of the Order of the Rising Sun, Japan’s highest award to other than members of the Imperial Family and heads of state; the Islamic Republic of Pakistan’s Sitara-i-Eisaar award, Pakistan’s highest award for humanitarian relief; the Presidential Distinguished Service Award for contributions to health services in Uganda; the United Nations Association of the United States of America’s Global Leadership Award; the Woodrow Wilson Institute Corporate Service Award, Columbia University’s Teachers College Cleveland E. Dodge Medal for Distinguished Service to Education; Stanford University’s Graduate School of Business Arbuckle Award and Excellence in Leadership Award; and an honorary doctorate in engineering from Polytechnic University.

Back to top

Katherine Burke

Katherine Burke grew up in Rochester, New York, and attended Harvard College and Northwestern University’s Kellogg School of Management. She worked for 15 years in journalism, as a reporter, editor, and publisher for such publications as The Boston Globe, Inside Sports, and The American Lawyer. She lives in San Francisco with her husband and three sons.

Back to top

Gary M. Cohen

Gary Cohen is Executive Vice President of BD (Becton, Dickinson and Company), a global medical technology company with 2007 turnover of $6.5 billion and 28,000 employees. He is a board director of the Perrigo Company, the US Fund for UNICEF, the CDC Foundation, Accordia Global Health Foundation and the Rutgers School of Business board of advisers, and is a member of the private sector delegation to the Global Fund. He also serves as Chair of the CDC Corporate Roundtable. Gary and the BD team dedicate their efforts to helping address infectious diseases that have reached pandemic proportions in developing countries. He serves as an advocate, speaker and expert panelist in forums involving child health, HIV/AIDS and health system strengthening. Gary has been honored with the Corporate Leadership Award by MESAB (Medical Education for South African Blacks), and with the Distinguished Humanitarian Award by B’nai B’rith International. He joined BD in 1983 as a marketing research analyst, and has held various positions in general management including President, Worldwide Injection, President, Europe, Middle East and Africa, and President, BD Medical.

Back to top

Susan Desmond-Hellmann, MD, MPH

Susan Desmond-Hellmann is President, Product Development at Genentech. In this role, Hellmann is responsible for Genentech's Development, Process Research & Development, Business Development, Product Portfolio Management, Alliance Management and Pipeline Planning Support functions. Hellmann is a member of Genentech’s executive committee. Hellmann joined Genentech in 1995 as a clinical scientist and she was named executive vice president, Development and Product Operations in 1999, and chief medical officer in 1996. In addition to her work at Genentech, Hellmann is an adjunct associate professor at the University of California, San Francisco (UCSF). Hellmann is board-certified in Internal Medicine and Medical Oncology and completed her clinical training at UCSF. In March 2004, Hellmann was named to her current role as president, Product Development. Prior to joining Genentech, Hellmann was associate director of clinical cancer research at Bristol-Myers Squibb’s Pharmaceutical Research Institute. While at Bristol-Myers Squibb, she was the project team leader for Taxol. Hellmann has also served as Assistant Professor, Hematology-Oncology at UCSF. During her nine years of training in internal medicine and oncology, Hellmann spent two years as visiting faculty at the Uganda Cancer Institute studying AIDS and cancer. She also spent two years in private practice before returning to clinical research. Hellmann was named to the Biotech Hall of Fame in 2007 and as Healthcare Businesswomen’s Association’s “Woman of the Year” for 2006. She was named to FORTUNE magazine’s 2007, 2006, 2005, 2004, 2003 and 2001 “Top 50 Most Powerful Women in Business” list. In 2006, 2005 and 2004, The Wall Street Journal listed Hellmann as one of its “Women To Watch.” In 2005 she was elected to the American Association for Cancer Research Board of Directors, and in 2001 she was named to the board of directors of the Biotechnology Industry Organization. Hellmann serves on the corporate board of Affymetrix. Hellmann received her Bachelor of Science in pre-medicine and her medical degree from the University of Nevada, Reno. She also holds a Master of Public Health degree from the University of California, Berkeley.

Back to top

Joseph M. Feczko, MD

Joseph Feczko is currently Senior Vice President and Chief Medical Officer of Pfizer Inc, with global responsibility for all aspects of the company’s medical affairs. Following a medical career specializing in internal medicine and infectious diseases, he worked in the UK for Pfizer and Glaxo, where his roles included Medical Director and Director of Global Regulatory Operations. He is a Board Member of the Technology Strategy Board for the Department of Trade & Industry, UK; Advisory Board of Center for Aging Research, University of Miami; International Trachoma Initiative; American Federation for Aging Research; the National Foundation of Infectious Diseases; the NY Academy of Medicine; he is also a member of the Pharmaceutical Drug Forum of the Institute of Medicine, and the Accordia Global Health Foundation Board, as well as the International Longevity Center Board. And most recently was appointed to the Boards of Research!America and the Foundation for the National Institutes of Health.

Back to top

Warner C. Greene, MD, PhD

Warner C. Greene, MD, PhD is the founding director of the Gladstone Institute of Virology and Immunology (GIVI), the Nick and Sue Hellmann Distinguished Professor of Translational Medicine, is Professor of Medicine, Microbiology and Immunology at the University of California, San Francisco (UCSF), and is President of Accordia Global Health Foundation. Under his direction GIVI has established an international reputation for excellence in the study of HIV and AIDS. Dr. Greene also serves as co-director of the federally funded UCSF-GIVI Center for AIDS Research. The author of more than 325 scientific papers, Dr. Greene has been honored by outstanding investigator awards from the American Federation for Clinical Research and the American College of Rheumatology and has been recognized as one of the 100 most-cited scientists in the world. He is a fellow of the American Academy for the Advancement of Science, a Councilor of the Association of American Physicians, and a member of the Institute of Medicine of the National Academies.

Back to top

Donald A. Holzworth, MS

Donald A. Holzworth is Chairman of Futures Group International, a global provider of public health and social programs designed to lessen the burden of infectious disease in more than 30 developing countries around the world. Holzworth serves on the Presidential Advisory Council on HIV/AIDS (PACHA).  He is the Founder and Chairman of Expression Analysis, a genomic services company; and Chairman of Casey Petraceuticals, a pet nutrition products company. He serves on the Board of the Campbell Alliance Group a management consulting firm serving the pharmaceutical and biotech industries. He is an Adjunct Professor of Health Policy and Administration and a member of the University of North Carolina at Chapel Hill School of Public Health's Advisory Board, the University of North Carolina at Chapel Hill’s Board of Visitors, and serves on Advisory Board for Southern Capitol Ventures.

Back to top

Robert Mallett

Robert L. Mallett is Senior Vice President, Worldwide Alliance Development, Philanthropy, and Corporate Responsibility, and President of the Pfizer Foundation. He has direct supervision of Pfizer’s worldwide groups encompassing philanthropy and corporate giving, alliance development, corporate responsibility, international affairs and multilateral institutions. He also co-chairs Pfizer’s Intellectual Property Task Force and co-leads the company’s efforts on enhancing global access to medicines. Prior to joining Pfizer in April 2001, Mr. Mallett served as Deputy Secretary of the U.S. Department of Commerce where he oversaw the administrative and policy operations of a number of key federal agencies, including, among others, the International Trade Administration, Economic Statistics Administration, Minority Business Development Agency, Census Bureau, and the U.S. Patent and Trademark Office. By appointment of the President, he served on the Board of the Overseas Private Investment Corporation and was a member of the 3-member Federal Steel Loan Guaranty Board. Prior to his federal executive service, Mr. Mallett was a shareholder and associate attorney at two major law firms in Washington, D.C. He also served as City Administrator and Deputy Mayor for the District of Columbia under Mayor Sharon Pratt Kelly, and Legal Counsel to former United States Senator Lloyd Bentsen. He has been an adjunct professor at Georgetown University’s Law Center, and was a Visiting Professor at Harvard University’s John F. Kennedy School of Government. He served as a law clerk to the Honorable John R. Brown of the United States Court of Appeals for the Fifth Circuit.Mr. Mallett is a member of the Council on Foreign Relations, an elected Fellow of the National Academy of Public Administrators, chair of the Board of Directors of the International Trachoma Initiative, co-chair, Appleseed Foundation, and Treasurer, Accordia Global Health Foundation. He is also on the boards of Fisk University, JHPIEGO (a Johns Hopkins University affiliate organization specializing in serving the health needs of families in developing countries), and the Joint Center for Political and Economic Studies. Mr. Mallett is the immediate past chairman of the U.S.-South Africa Business Council; the former chairman of the Board of Governors of Wesley Theological Seminary; and he is a former member of the boards of Medical Education for South African Blacks, and North General Hospital in New York’s historic Harlem community. Mr. Mallett is a Phi Beta Kappa graduate of Morehouse College (1979) and received his law degree from Harvard University in 1982, where he was Projects Editor of the Harvard Civil Right-Civil Liberties Law Review. He resides in New York City.

Back to top

Fred Port

Mr. Port retired as a Director of Callaway Golf and President of Callaway Golf International. He served in a variety of Board and senior management positions with several companies over 35 years with emphasis on strategic change, global operations, acquisitions and revitalization. In addition, he dedicated substantial effort to community activities -- most recently recognized nationally as Director of the Year for Court Appointed Special Advocates (CASA) -- for his almost 25 years of service. An honors graduate of the Anderson School at UCLA (MBA), he is a frequent speaker and mentor for those confronting cancer (he is a survivor).